PARP1 promotes NLRP3 activation via blocking TFEB-mediated autophagy in rotenone-induced neurodegeneration DOI Creative Commons
He Zhang,

Zhefan Xie,

Yongming Peng

et al.

Ecotoxicology and Environmental Safety, Journal Year: 2023, Volume and Issue: 252, P. 114630 - 114630

Published: Feb. 8, 2023

Rotenone, a widely used pesticide, causes dopaminergic neurons loss and increase the risk of Parkinson's disease (PD). However, few studies link role PARP1 to neuroinflammatory response autophagy dysfunction in rotenone-induced neurodegeneration. Here, we identified that overactivation caused by rotenone led NLRP3-mediated inflammation. Further results showed inhibition could reduce inflammation, which was effectively eliminated TFEB knockdown. Moreover, poly(ADP-ribosyl)ated reduced autophagy. Of note, rescue loss. Overall, our study revealed blocks through poly (ADP-ribosyl)ating inhibited NLRP3 degradation, suggests intervention PARP1-TFEB-NLRP3 signaling can be new treatment strategy for

Language: Английский

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity DOI Creative Commons
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar

et al.

Cells, Journal Year: 2023, Volume and Issue: 12(4), P. 659 - 659

Published: Feb. 19, 2023

Doxorubicin (DOX) constitutes the major constituent of anti-cancer treatment regimens currently in clinical use. However, precise mechanisms DOX’s action are not fully understood. Emerging evidence points to pleiotropic anticancer activity DOX, including its contribution DNA damage, reactive oxygen species (ROS) production, apoptosis, senescence, autophagy, ferroptosis, and pyroptosis induction, as well immunomodulatory role. This review aims collect information on DOX influence anti-tumor immune response, providing a rationale behind importance modern cancer therapy.

Language: Английский

Citations

289

Inhibitors of PARP: Number crunching and structure gazing DOI Creative Commons
Johannes Rudolph,

Karen Jung,

Karolin Luger

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2022, Volume and Issue: 119(11)

Published: March 8, 2022

SignificancePARP is an important target in the treatment of cancers, particularly patients with breast, ovarian, or prostate cancer that have compromised homologous recombination repair (i.e., BRCA

Language: Английский

Citations

84

PARP1: Liaison of Chromatin Remodeling and Transcription DOI Open Access
Wen Zong,

Yamin Gong,

Wenli Sun

et al.

Cancers, Journal Year: 2022, Volume and Issue: 14(17), P. 4162 - 4162

Published: Aug. 27, 2022

Poly(ADP-ribosyl)ation (PARylation) is a covalent post-translational modification and plays key role in the immediate response of cells to stress signals. Poly(ADP-ribose) polymerase 1 (PARP1), founding member PARP superfamily, synthesizes long branched polymers ADP-ribose (PAR) onto acceptor proteins, thereby modulating their function local surrounding. PARP1 most prominent PARPs responsible for production about 90% PAR cell. Therefore, PARylation play pleotropic wide range cellular processes, such as DNA repair genomic stability, cell death, chromatin remodeling, inflammatory gene transcription. has DNA-binding catalytic activities that are important repair, yet also modulate conformation transcription, which can be independent damage response. homeostasis have been implicated multiple diseases, including inflammation, stroke, diabetes cancer. Studies molecular action biological provide basis development pharmaceutic strategies clinical applications. This review focuses primarily on regulation remodeling transcriptional activation.

Language: Английский

Citations

48

Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke DOI
Yang Liu,

Lauren Guttman,

Valina L. Dawson

et al.

Biochemical Pharmacology, Journal Year: 2024, Volume and Issue: 228, P. 116174 - 116174

Published: March 27, 2024

Language: Английский

Citations

12

Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy DOI
Sihui Yu,

Hongyang Xiao,

Li Ma

et al.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal Year: 2023, Volume and Issue: 1878(5), P. 188946 - 188946

Published: June 28, 2023

Language: Английский

Citations

20

The natural product dehydrocurvularin induces apoptosis of gastric cancer cells by activating PARP-1 and caspase-3 DOI
Huibin Xu, Xiaoman Shen, Xiangke Li

et al.

APOPTOSIS, Journal Year: 2023, Volume and Issue: 28(3-4), P. 525 - 538

Published: Jan. 18, 2023

Language: Английский

Citations

16

MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment DOI Open Access
André T. S. Vicente, Jorge A. R. Salvador

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(19), P. 11068 - 11068

Published: Sept. 21, 2022

Proteolysis-targeting chimeras (PROTACs) are molecules that selectively degrade a protein of interest (POI). The incorporation ligands recruit mouse double minute 2 (MDM2) into PROTACs, forming the so-called MDM2-based has shown promise in cancer treatment due to its dual mechanism action: PROTAC recruits MDM2 prevents binding p53, resulting not only degradation POI but also increase intracellular levels p53 suppressor, with activation whole set biological processes, such as cell cycle arrest or apoptosis. In addition, these certain cases, allow for target, nanomolar potency, rapid and sustained manner over time, less susceptibility development resistance tolerance, without causing changes expression, selectivity including respective isoforms mutations, type, overcoming some limitations associated use inhibitors same therapeutic target. Therefore, aim this review is analyze discuss characteristics PROTACs developed oncogenic proteins understand what potential they have future anticancer drugs.

Language: Английский

Citations

26

Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer DOI

Hang Wu,

Xiyou Du,

Jiangkang Xu

et al.

Acta Biomaterialia, Journal Year: 2022, Volume and Issue: 157, P. 551 - 565

Published: Dec. 10, 2022

Language: Английский

Citations

21

The Role of Poly(ADP-ribose) Polymerase 1 in Nuclear and Mitochondrial Base Excision Repair DOI Creative Commons
Geoffrey K. Herrmann, Y. Whitney Yin

Biomolecules, Journal Year: 2023, Volume and Issue: 13(8), P. 1195 - 1195

Published: July 31, 2023

Poly(ADP-ribose) (PAR) Polymerase 1 (PARP-1), also known as ADP-ribosyl transferase with diphtheria toxin homology (ARTD-1), is a critical player in DNA damage repair, during which it catalyzes the ADP ribosylation of self and target enzymes. While nuclear localization PARP-1 has been well established, recent studies suggest its mitochondrial localization. In this review, we summarize differences between Base Excision Repair (BER) pathways, involvement BER, functional interplay other BER

Language: Английский

Citations

11

Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review DOI
Ziqiang Liu, Qian Zhang, Yulin Liu

et al.

Bioorganic & Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 111, P. 117847 - 117847

Published: July 28, 2024

Language: Английский

Citations

4